GLP-1 treatments represent a new generation of approach for managing type 2 diabetes and, increasingly, weight reduction. Tirzepatidus, Semaglutide, and the newer substance Retatrutide are prominent examples within this category. These medicines work by mimicking the body's natural GLP-1 substance, stimulating insulin secretion and suppressing suga